RxDoctor Payments Data

Tori Siler, PA

Physician Assistant · Dundalk, MDNPI 1528839891

Payments from drug & device makers

$1,496in general payments, 2019–2025

Across 88 payments — averaging $17.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$460
  • Saluda Medical Americas, Inc.$252
  • Collegium Pharmaceutical, Inc.$144
  • Vertex$141
  • Averitas Pharma Inc.$123
  • Electronic Waveform Lab, Inc.$73
  • plus $303 from 10 others

What the payments were for

  • Food & beverage$1,496100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,496 in reported general payments places this provider in the 80th percentile of 2,567 physician assistant providers in Maryland.

See all physician assistant providers in Maryland

Medicare billing

Part B allowed, 2024
$109,489
Medicare patients
280
Services billed
1,099

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl670$11,034
Xtampza ErOxycodone Myristate17$7,580
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen195$4,587
ZtlidoLidocaine11$4,041
Pregabalin188$3,882
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen185$3,510
Gabapentin267$3,157
Naloxone Hcl25$2,204
Lidocaine26$1,802
Cyclobenzaprine Hcl113$1,037
Tramadol Hcl126$889
Diclofenac Sodium31$671
Ibuprofen60$585
Tizanidine Hcl63$447
Methocarbamol44$423

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er$144$7,58017 claims
Scilex Pharmaceuticals Inc.Ztlido$41$4,04111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,567 physician assistant providers in Maryland.

Other physician assistant in Dundalk

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →